Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Oncology clinical trials present unique challenges for investigative sites, including complex trial designs, challenging eligibility criteria, and invasive procedures. In addition, the oversaturation of trials leads to competition for patients and experienced sites.
The third episode of Enabling Successful Sites features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Mitch Carter (Associate Director, Global Site Alliances), and Angela Galindo, (Vice President, Client Engagement at START Network) as they talk about the competition for patients and experienced sites for oncology trials, why a site would pass on a study opportunity and how we can make oncology studies less burdensome for both patients and sites.
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024